Interaction of CD44 with different forms of hyaluronic acid. Its role in adhesion and migration of tumor cells

被引:41
作者
Alaniz, L
Cabrera, PV
Blanco, G
Ernst, G
Rimoldi, G
Alvarez, E
Hajos, SE
机构
[1] Univ Nacl Buenos Aires, Catedra Inmunol IDEHU, Fac Farm & Bioquim, Buenos Aires, DF, Argentina
[2] Univ Nacl Buenos Aires, Catedra Patol Basica, Fac Vet, Buenos Aires, DF, Argentina
关键词
CD44; hyaluronic acid; lymphoma dissemination; T-cell lymphoma lines;
D O I
10.1080/15419060214522
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interaction between hyaluronic acid (HA) and CD44 has been considered a key event in tumor invasion and metastasis. HA is a linear, high molecular weight glycosaminoglycan in its native state, but fragmented low molecular forms are found at sites of neoplastic or inflammatory infiltrates. Both high and low molecular weights HA are involved in diverse biological functions. In this study, we used two clonal variants of a T cell murine lymphoma designated LBLa and LBLc. These cell lines were found to differ in their in vivo and in vitro growth rates. LBLa grew faster and exhibited an enhanced invasive capacity as compared to LBLc. In contrast, cell lines did not differ in the expression of surface markers (CD8, CD24, CD25, CD44, and CD18), or in their capacity to bind HA. However, LBLa cells exhibited higher capacity to migrate to low molecular weight HA than did LBLc. Migration was mediated by CD44 since it was abrogated by anti-CD44 monoclonal antibody as well as by hyaluronidase. We suggest that interaction between CD44 and low molecular weight HA may trigger migration mechanisms in LBLa cells, thus contributing to enhanced invasive cell capacity.
引用
收藏
页码:117 / 130
页数:14
相关论文
共 41 条
[31]   Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments [J].
Rockey, DC ;
Chung, JJ ;
McKee, CM ;
Noble, PW .
HEPATOLOGY, 1998, 27 (01) :86-92
[32]  
Roden L, 1989, CIBA F SYMP, P76
[33]   CONCOMITANT IMMUNITY IN MURINE TUMORS OF NON-DETECTABLE IMMUNOGENICITY [J].
RUGGIERO, RA ;
BUSTUOABAD, OD ;
BONFIL, RD ;
MEISS, RP ;
PASQUALINI, CD .
BRITISH JOURNAL OF CANCER, 1985, 51 (01) :37-48
[34]   GENOMIC STRUCTURE OF DNA ENCODING THE LYMPHOCYTE HOMING RECEPTOR CD44 REVEALS AT LEAST 12 ALTERNATIVELY SPLICED EXONS [J].
SCREATON, GR ;
BELL, MV ;
JACKSON, DG ;
CORNELIS, FB ;
GERTH, U ;
BELL, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (24) :12160-12164
[35]   THE HEMATOPOIETIC AND EPITHELIAL FORMS OF CD44 ARE DISTINCT POLYPEPTIDES WITH DIFFERENT ADHESION POTENTIALS FOR HYALURONATE-BEARING CELLS [J].
STAMENKOVIC, I ;
ARUFFO, A ;
AMIOT, M ;
SEED, B .
EMBO JOURNAL, 1991, 10 (02) :343-348
[36]   DISTINCT EFFECTS OF 2 CD44 ISOFORMS ON TUMOR-GROWTH INVIVO [J].
SY, MS ;
GUO, YJ ;
STAMENKOVIC, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04) :859-866
[37]   Keratan sulfate modification of CD44 modulates adhesion to hyaluronate [J].
Takahashi, K ;
Stamenkovic, I ;
Cutler, M ;
Dasgupta, A ;
Tanabe, KK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) :9490-9496
[38]   Receptor-ligand interaction between CD44 and osteopontin (Eta-1) [J].
Weber, GF ;
Ashkar, S ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 1996, 271 (5248) :509-512
[39]   Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion [J].
Yu, Q ;
Stamenkovic, I .
GENES & DEVELOPMENT, 1999, 13 (01) :35-48
[40]  
ZAHALKA MA, 1993, J IMMUNOL, V150, P4466